Impax Laboratories to Present at the Bank of America Merrill Lynch 2013 Health Care Conference

  Impax Laboratories to Present at the Bank of America Merrill Lynch 2013
  Health Care Conference

Bank of America Merrill Lynch 2013 Healthcare Conference

Business Wire

HAYWARD, Calif. -- May 10, 2013

Impax Laboratories, Inc. (NASDAQ: IPXL) today announced that the Company will
present at the Bank of America Merrill Lynch Health Care Conference on
Thursday, May 16, at 8:00 a.m. Pacific Standard Time. The conference will be
held at the Encore at Wynn Las Vegas, Las Vegas, NV.

Individuals may listen to the live or an archived presentation made at the
conference, which will be posted in the investor relations section of the
Company’s web site at www.impaxlabs.com. This presentation will be archived on
the Company’s web site for 30 days.

About Impax Laboratories, Inc.

Impax Laboratories, Inc. (Impax) is a technology based specialty
pharmaceutical company applying its formulation expertise and drug delivery
technology to the development of controlled-release and specialty generics in
addition to the development of central nervous system disorder branded
products. Impax markets its generic products through its Global
Pharmaceuticals division and markets its branded products through the Impax
Pharmaceuticals division. Additionally, where strategically appropriate, Impax
develops marketing partnerships to fully leverage its technology platform and
pursues partnership opportunities that offer alternative dosage form
technologies, such as injectables, nasal sprays, inhalers, patches, creams and
ointments. For more information, please visit the Company's Web site at:
www.impaxlabs.com.

Contact:

Impax Laboratories, Inc.
Mark Donohue
Investor Relations and Corporate Communications
(215) 558-4526
www.impaxlabs.com
 
Press spacebar to pause and continue. Press esc to stop.